This is an aggregated industry headline. Read the full story at Drug Channels →
Drug Channels News Roundup, March 2026: Cigna’s 340B Workaround, Merck’s ARPA Surprise, Walgreens’ Automation Bet, Why Rebates Hurt Patients, and a DCI Team Photo
Spring is here in always-sunny Philadelphia. The vernal equinox has brought us an unexpected bounty of noteworthy news: Cigna’s clever vertical integration move Merck cuts drug prices—and Medicaid and 340B pay more Walgreens’ big pharmacy technology play How plans profit—and patients lose—from highl
By Drug Channels
· Mar 31, 2026
· via Drug Channels
Tags
theweekformat:headlineheadlineDrug Channels
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.
More from The Week
All The Week →
The WeekFiercePharma ↗
For Meghan O'Hora, pharma marketing isn't about patients. It's about people and making real connections that h…
The WeekFierceBiotech ↗
Anti-aging startup NewLimit is back with a fresh fundraise of $435 million after landing on its first clinic-r…
The WeekBriefing
The agency’s Complete Response Letter delays CTx‑1301, the biotech’s first commercial hopeful, over CMC issues…